Pictorial review of SPECT/CT imaging applications in clinical nuclear medicine

Autor Bhargava, Peeyush, He, Guocheng, Samarghandi, Amin, Delpassand, Ebrahim S
Vydáno 2012

The value of (68)Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature

Autor Mojtahedi, Alireza, Thamake, Sanjay, Tworowska, Izabela, Ranganathan, David, Delpassand, Ebrahim S
Vydáno 2014

Preclinical investigation of (212)Pb-DOTAMTATE for peptide receptor radionuclide therapy in a neuroendocrine tumor model

Autor Rozgaja Stallons, Tania A, Saidi, Amal, Tworowska, Izabela, Delpassand, Ebrahim S, Torgue, Julien J
Vydáno v Mol Cancer Ther (2019)

Assessment of vulnerable atherosclerotic and fibrotic plaques in coronary arteries using (68)Ga-DOTATATE PET/CT

Autor Mojtahedi, Alireza, Alavi, Abass, Thamake, Sanjay, Amerinia, Reza, Ranganathan, David, Tworowska, Izabela, Delpassand, Ebrahim S
Vydáno v Am J Nucl Med Mol Imaging (2014)

Radiosynthesis of clinical doses of (68)Ga-DOTATATE (GalioMedix™) and validation of organic-matrix-based (68)Ge/(68)Ga generators

Autor Tworowska, Izabela, Ranganathan, David, Thamake, Sanjay, Delpassand, Ebrahim, Mojtahedi, Alireza, Schultz, Michael K., Zhernosekov, Konstantin, Marx, Sebastian
Vydáno v Nucl Med Biol (2015)

Peptide Receptor Radionuclide Therapy with Lu-177 Octreotate in patients with Somatostatin Receptor Expressing Neuroendocrine Tumors: Six Years Assessment

Autor Delpassand, Ebrahim S., Hamiditabar, Mohammadali, Ali, Muzammil, Roys, Joseph, Wolin, Edward M., O’Dorisio, Thomas M., Ranganathan, David, Strosberg, Jonathan R.
Vydáno v Clin Nucl Med (2017)

Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High...

Autor Delpassand, Ebrahim S., Samarghandi, Amin, Mourtada, Jennifer Sims, Zamanian, Sara, Espenan, Gregory D., Sharif, Roozbeh, MacKenzie, Shawn, Kosari, Kambiz, Barakat, Omar, Naqvi, Shagufta, Seng, John E., Anthony, Lowell
Vydáno 2012

Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with (177)Lu-Dotatate: an analysis of the NETTER-1 study

Autor Strosberg, Jonathan, Kunz, Pamela L., Hendifar, Andrew, Yao, James, Bushnell, David, Kulke, Matthew H., Baum, Richard P., Caplin, Martyn, Ruszniewski, Philippe, Delpassand, Ebrahim, Hobday, Timothy, Verslype, Chris, Benson, Al, Srirajaskanthan, Rajaventhan, Pavel, Marianne, Mora, Jaume, Berlin, Jordan, Grande, Enrique, Reed, Nicholas, Seregni, Ettore, Paganelli, Giovanni, Severi, Stefano, Morse, Michael, Metz, David C., Ansquer, Catherine, Courbon, Frédéric, Al-Nahhas, Adil, Baudin, Eric, Giammarile, Francesco, Taïeb, David, Mittra, Erik, Wolin, Edward, O’Dorisio, Thomas M., Lebtahi, Rachida, Deroose, Christophe M., Grana, Chiara M., Bodei, Lisa, Öberg, Kjell, Polack, Berna Degirmenci, He, Beilei, Mariani, Maurizio F., Gericke, Germo, Santoro, Paola, Erion, Jack L., Ravasi, Laura, Krenning, Eric
Vydáno v Eur J Nucl Med Mol Imaging (2020)